Qube Research & Technologies (QRT)’s Gilead Sciences GILD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.3M	Sell	45,200 -8,300	-16%	-$1.16M	0.01%	1543
2025 Q4	$6.57M	Buy	53,500 +19,900	+59%	+$2.42M	0.01%	1606
2025 Q3	$3.73M	Sell	33,600 -238,800	-88%	-$27.1M	﹤0.01%	1923
2025 Q2	$30.2M	Sell	272,400 -1,047,000	-79%	-$111M	0.03%	678
2025 Q1	$148M	Buy	1,319,400 +1,282,900	+3,515%	+$132M	0.17%	140
2024 Q4	$3.37M	Buy	36,500 +2,700	+8%	+$243K	﹤0.01%	1674
2024 Q3	$2.83M	Sell	33,800 -425,700	-93%	-$32.5M	﹤0.01%	1619
2024 Q2	$31.5M	Buy	459,500 +342,100	+291%	+$22.8M	0.05%	440
2024 Q1	$8.6M	Sell	117,400 -120,100	-51%	-$9.24M	0.01%	930
2023 Q4	$19.2M	Buy	237,500 +61,000	+35%	+$4.75M	0.04%	528
2023 Q3	$13.2M	Buy	176,500 +38,000	+27%	+$2.92M	0.03%	535
2023 Q2	$10.7M	Buy	+138,500	New	+$11M	0.04%	520

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Qube Research & Technologies (QRT)'s GILD Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Gilead Sciences (GILD) stake by 95% in Q1 2026, selling an estimated $340M and leaving 121,052 shares worth $16.9M. The position accounts for 0.02% of the portfolio, ranked #970.

Qube Research & Technologies (QRT) first reported a position in GILD in Q1 2018 and has held it in 28 quarters since. The position peaked at $536M in Q3 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Qube Research & Technologies (QRT) held 121,052 shares of Gilead Sciences worth $16.9M as of Q1 2026.
Qube Research & Technologies (QRT) sold 2,425,986 Gilead Sciences shares in Q1 2026, an estimated $340M.
Gilead Sciences made up 0.02% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #970 holding.
Qube Research & Technologies (QRT) first reported a position in Gilead Sciences in Q1 2018 and has held it in 28 quarters since.
Qube Research & Technologies (QRT)'s Gilead Sciences position peaked at $536M in Q3 2025.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.